Literature DB >> 22017539

Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.

Steven J Taylor1, Asitha Abeywardane, Shuang Liang, Ingo Muegge, Anil K Padyana, Zhaoming Xiong, Melissa Hill-Drzewi, Bennett Farmer, Xiang Li, Brandon Collins, John Xiang Li, Alexander Heim-Riether, John Proudfoot, Qiang Zhang, Daniel Goldberg, Ljiljana Zuvela-Jelaska, Hani Zaher, Jun Li, Neil A Farrow.   

Abstract

Matrix metalloproteases (MMPs) play an important role in cartilage homeostasis under both normal and inflamed disease states and, thus, have become attractive targets for the treatment of arthritic diseases. Herein, we describe the identification of a potent, selective MMP-13 inhibitor, developed using fragment-based structure-guided lead identification and optimization techniques. Virtual screening methods identified a novel, indole-based MMP-13 inhibitor that bound into the S1' pocket of the protein exhibiting a novel interaction pattern hitherto not observed in MMP-13 inhibitors. X-ray crystallographic structures were used to guide the elaboration of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over nine other MMP isoforms tested.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017539     DOI: 10.1021/jm201129m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

2.  Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel.

Authors:  Shahrbanoo Jahangir; David Eglin; Naomi Pötter; Mojtaba Khozaei Ravari; Martin J Stoddart; Ali Samadikuchaksaraei; Mauro Alini; Mohammadreza Baghaban Eslaminejad; Majid Safa
Journal:  Stem Cell Res Ther       Date:  2020-10-09       Impact factor: 6.832

3.  Merging allosteric and active site binding motifs: de novo generation of target selectivity and potency via natural-product-derived fragments.

Authors:  Jan Lanz; Rainer Riedl
Journal:  ChemMedChem       Date:  2014-12-08       Impact factor: 3.466

4.  Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.

Authors:  Thomas Fischer; Rainer Riedl
Journal:  ChemMedChem       Date:  2013-07-26       Impact factor: 3.466

5.  Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.

Authors:  Thomas Fischer; Rainer Riedl
Journal:  Int J Mol Sci       Date:  2016-03-01       Impact factor: 5.923

6.  Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.

Authors:  Milon Mondal; M Yagiz Unver; Asish Pal; Matthijs Bakker; Stephan P Berrier; Anna K H Hirsch
Journal:  Chemistry       Date:  2016-09-07       Impact factor: 5.236

7.  Indole Inhibitors of MMP-13 for Arthritic Disorders.

Authors:  Steven J Taylor; Asitha Abeywardane; Shuang Liang; Zhaoming Xiong; John R Proudfoot; Bennett Sandy Farmer; Donghong A Gao; Alexander Heim-Riether; Lana Louise Smith-Keenan; Ingo Muegge; Yang Yu; Qiang Zhang; Donald Souza; Mark Panzenbeck; Daniel Goldberg; Melissa Hill-Drzewi; Mariana Margarit; Brandon Collins; John Xiang Li; Ljiljana Zuvela-Jelaska; Jun Li; Neil A Farrow
Journal:  ACS Omega       Date:  2021-07-19

8.  Using a fragment-based approach to target protein-protein interactions.

Authors:  Duncan E Scott; Matthias T Ehebauer; Tara Pukala; May Marsh; Tom L Blundell; Ashok R Venkitaraman; Chris Abell; Marko Hyvönen
Journal:  Chembiochem       Date:  2013-01-23       Impact factor: 3.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.